Your browser doesn't support javascript.
loading
Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy.
Graham, Jeffrey; Wells, John Connor; Dudani, Shaan; Gan, Chun L; Donskov, Frede; Lee, Jae-Lyun; Kollmannsberger, Christian K; Meza, Luis; Beuselinck, Benoit; Hansen, Aaron; North, Scott A; Bjarnason, Georg A; Sayegh, Nicolas; Kanesvaran, Ravindran; Wood, Lori A; Hotte, Sebastien J; McKay, Rana R; Choueiri, Toni K; Heng, Daniel Y C.
Afiliación
  • Graham J; University of Manitoba, Winnipeg, MB, Canada; CancerCare Manitoba Research Institute, CancerCare Manitoba, Winnipeg, MB, Canada. Electronic address: jgraham9@cancercare.mb.ca.
  • Wells JC; Queen's University, Kingston, ON, Canada.
  • Dudani S; Division of Oncology/Hematology, William Osler Health System, Brampton, ON, Canada.
  • Gan CL; University of Calgary, Calgary, Alberta, Canada.
  • Donskov F; Aarhus University Hospital, Aarhus, Denmark.
  • Lee JL; Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea.
  • Kollmannsberger CK; BC Cancer-Vancouver Centre, Vancouver, BC, Canada.
  • Meza L; Department of Medical Oncology and Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Beuselinck B; Leuven Cancer Institute, Universitaire Ziekenhuizen, Leuven, Belgium.
  • Hansen A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • North SA; University of Alberta Cross Cancer Institute, Edmonton, AB, Canada.
  • Bjarnason GA; Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada.
  • Sayegh N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Kanesvaran R; National Cancer Centre Singapore, Singapore.
  • Wood LA; Dalhousie University, Halifax, NS, Canada.
  • Hotte SJ; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • McKay RR; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.
  • Choueiri TK; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Heng DYC; University of Calgary, Calgary, Alberta, Canada.
Eur J Cancer ; 171: 124-132, 2022 08.
Article en En | MEDLINE | ID: mdl-35717820
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article